Prima, Austin Research Institute deal

PRR completed its acquisition of the institute's share and option holdings in four PRR subsidiaries (see BioCentury, Aug.15). PRR now owns all shares of Oncomab Pty Ltd., Panvax Ltd., Cancer Vac Pty ...